Other languages Implantica AG

Equities

IMP A SDB

SE0014855029

Market Closed - Nasdaq Stockholm Other stock markets 11:12:16 2024-04-24 am EDT			5-day change	1st Jan Change
28 ^SEK	-2.78%		-3.11%	+17.15%

Mar. 27	Implantica Submits Initial Module of US FDA Premarket Approval Application for GERD Medical Device	MT
Mar. 27	Implantica Submits U.S. FDA Premarket Approval Application for RefluxStop® (first module)	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Implantica Submits Initial Module of US FDA Premarket Approval Application for GERD Medical Device	Mar. 27
Implantica Submits U.S. FDA Premarket Approval Application for RefluxStop® (first module)	Mar. 27
Implantica Completes Human Factors Validation Study for RefluxStop as Part of the US FDA Premarket Approval Process	Mar. 26
Implantica to Deploy GERD Treatment in Spain	Mar. 19
Implantica AG (publ.) Wins Another RefluxStop Public Tender in Europe with Hospital Universitario De Getafe	Mar. 19
Implantica AG (OM:IMP A SDB) acquired IRCCS Saverio De Bellis.	Mar. 04
Implantica AG Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 16
Implantica Announces Completion of its First RefluxStop Procedures at Artemed Klinikum München Süd in Munich, Germany	Feb. 15
Implantica Announces First Refluxstop Public Tender Win, Paving the Way for Permanent Reimbursement in Italy	Feb. 13
Implantica Ag Announces the First RefluxStop Procedures Completed At MIC Hospital in Berlin	Feb. 06
Implantica AG (publ.) Adds Another RefluxStop Center in Spain	Dec. 18
Implantica AG Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 22
Implantica AG (publ.)'s RefluxStop Offers for the First Time in the NHS in UK	Nov. 21
Implantica Wins EU Medical Device Certifications	23-09-07
Implantica AG Receives MDR Certification for RefluxStop?	23-09-07
Implantica AG Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-24
Implantica AG Further Expands Its Commercial Footprint in Italy	23-06-29
Implantica AG Announces RefluxStop Results Were Presented At the DDW Conference in Chicago	23-05-16
Implantica AG Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-12
Implantica AG (OM:IMP A SDB) commences an Equity Buyback Plan, under the authorization approved on May 10, 2022.	23-04-06

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Implantica AG

Equities

IMP A SDB

SE0014855029

Other languages

Filters